Cleared Traditional

K830094 - USCI TEMP. ATRIO-VENTRICULAR ELECTRODE

K830094 is the FDA 510(k) clearance for USCI TEMP. ATRIO-VENTRICULAR ELECTRODE by C.R. Bard, Inc.. It is a Class 2 Cardiovascular device (product code LDF) cleared through the Traditional 510(k) pathway after a 38-day FDA review.

K830094 · C.R. Bard, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1983
Decision
38d
Days
Class 2
Risk

K830094 is an FDA 510(k) clearance for the USCI TEMP. ATRIO-VENTRICULAR ELECTRODE. Classified as Electrode, Pacemaker, Temporary (product code LDF), Class II - Special Controls.

Submitted by C.R. Bard, Inc. (Mchenry, US). The FDA issued a Cleared decision on February 18, 1983 after a review of 38 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.3680 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all C.R. Bard, Inc. devices

Submission Details

510(k) Number K830094 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 11, 1983
Decision Date February 18, 1983
Days to Decision 38 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
87d faster than avg
Panel avg: 125d · This submission: 38d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LDF Electrode, Pacemaker, Temporary
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.3680
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - LDF Electrode, Pacemaker, Temporary

All 74
Devices cleared under the same product code (LDF) and FDA review panel - the closest regulatory comparables to K830094.
EPCOR MULTIELECTRODE TEMP. PERVENOUS
K832561 · Cordis Corp. · Oct 1983
ELECATH PACEWEDGE DUAL PRESS. BIPOLAR
K832850 · Electro-Catheter Corp. · Oct 1983
TEMP. PACING LEAD, BIPOLAR #TH60, 90/110
K830772 · Oscor, Inc. · Apr 1983
TRANSLUMINAL BIPOLAR PACING PROBE
K813521 · American Edwards Laboratories · Mar 1982
ETHICON* TEMP. CARDIAC PACING WIRE
K813138 · Ethicon, Inc. · Dec 1981
MODEL 5867-12 BIPOLAR LOW-PROFILE LEAD
K812725 · Medtronic Vascular · Nov 1981